Filters close
Released: 23-Nov-2015 5:05 PM EST
WashU Expert: Pfizer deal marks the end of U.S. ability to stop corporate tax inversion
Washington University in St. Louis

Article Body 2010U.S. pharmaceutical giant Pfizer announced Nov. 23 a record-breaking $160 billion merger with Irish firm Allergan, the biggest merger to-date involving the controversial strategy of tax inversion. The move marks the beginning of the end of the ability to stop corporate tax inversions under current tax rules, said an expert on international tax law at Washington University in St.



close
0.71418